Clinical Trial

PARTNER 3 Trial - Aortic Valve-in-Valve

Name: PARTNER 3 Trial - Aortic Valve-in-Valve — clinical trial record (NCT03003299)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This study will assess the safety and effectiveness of the SAPIEN 3/SAPIEN 3 Ultra transcatheter heart valve (THV) in patients with a failing aortic bioprosthetic valve.

Protocol Amendment History 17 amendments

This ClinicalTrials.gov record has been amended 17 times since 2016-12-21; most recent amendment 2024-05-08.

Status change: Not Yet Recruiting → Recruiting 2017-01-31

Trial Details

NCT Number	NCT03003299
Lead Sponsor	Edwards Lifesciences
Conditions	Aortic Stenosis, Aortic Stenosis, Severe
Enrollment	125 participants
Start Date	2017-01-05
Primary Completion	2033-01 (estimated)
Study Completion	2038-04 (estimated)
Updated on ClinicalTrials.gov	2024-05-10